A McGill University-led study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain ...

New research reveals that people with cannabis use disorder (CUD) have elevated dopamine levels in a brain region associated ...

A 33-year-old woman hears brutal and frightening voices daily but continues her college studies. A middle-aged man, who served in the Navy and has since struggled with substance ...

Discover how schizophrenia affects work life, and explore strategies for obtaining work accommodations, establishing support, ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Washingtonians with schizophrenia are curious about a recently FDA-approved drug to treat their symptoms but much is unknown about how well it works.

A McGill University-led study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

New guidelines have been developed for the treatment of schizophrenia after a collaboration of international experts from 30 ...